Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | AMGN | REGN | BMY | GILD |
| Company | Vertex Pharmaceutic | Amgen Inc | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 472.00 | 322.05 | 1,054.06 | 51.95 | 83.82 |
| High | 472.31 | 322.20 | 1,061.60 | 52.97 | 83.98 |
| Low | 461.36 | 316.92 | 1,040.40 | 51.61 | 82.82 |
| Last | 469.76 | 320.32 | 1,046.91 | 52.90 | 83.94 |
| Change | +4.68 | -1.89 | -4.33 | +1.16 | +0.10 |
| % Change | +1.01% | -0.59% | -0.41% | +2.24% | +0.12% |
| Volume | 1,128,800 | 2,097,300 | 599,300 | 17,436,199 | 6,619,000 |
| 20-Day Average Volume | 972,565 | 2,108,665 | 635,445 | 11,996,120 | 7,910,090 |
| Previous Close | 465.08 | 322.21 | 1,051.24 | 51.74 | 83.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 471.45 | 328.05 | 1,114.28 | 49.82 | 82.32 |
| 20-Day Raw Stochastic | 40.17% | 30.21% | 22.14% | 98.71% | 86.71% |
| 20-Day Relative Strength | 47.47% | 45.20% | 36.64% | 65.66% | 67.23% |
| Weighted Alpha | +26.81 | +18.40 | +21.57 | +1.62 | +18.18 |
| Today's Opinion | 8% Buy | 24% Buy | 24% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 8% Buy | 56% Buy | 24% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 80% Buy | 96% Buy | 100% Buy | 56% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.46% since 09/24/24 | -3.20% since 09/24/24 | +0.09% since 09/24/24 | +3.85% since 09/24/24 | +0.18% since 09/24/24 |
| Low | 458.10 on 09/26/24 | 312.16 on 09/25/24 | 1,008.41 on 09/25/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 |
| High | 472.31 on 10/01/24 | 329.50 on 09/25/24 | 1,070.00 on 09/27/24 | 52.97 on 10/01/24 | 84.33 on 09/27/24 |
| 1-Month | |||||
| %Chg | -5.27% since 08/30/24 | -4.05% since 08/30/24 | -11.63% since 08/30/24 | +5.91% since 08/30/24 | +6.25% since 08/30/24 |
| Low | 456.07 on 09/24/24 | 312.16 on 09/25/24 | 1,008.41 on 09/25/24 | 47.55 on 09/09/24 | 77.74 on 09/05/24 |
| High | 493.00 on 09/03/24 | 339.17 on 09/23/24 | 1,192.54 on 09/03/24 | 52.97 on 10/01/24 | 84.89 on 09/12/24 |
| 3-Month | |||||
| %Chg | -0.32% since 07/01/24 | +2.99% since 07/01/24 | -0.96% since 07/01/24 | +28.09% since 07/01/24 | +22.29% since 07/01/24 |
| Low | 456.07 on 09/24/24 | 306.11 on 07/03/24 | 1,008.41 on 09/25/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 |
| High | 510.64 on 08/01/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 52.97 on 10/01/24 | 84.89 on 09/12/24 |
| 6-Month | |||||
| %Chg | +11.72% since 04/01/24 | +13.17% since 04/01/24 | +8.01% since 04/01/24 | -0.17% since 04/01/24 | +15.18% since 04/01/24 |
| Low | 391.01 on 04/18/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 510.64 on 08/01/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 53.35 on 04/02/24 | 84.89 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 120,015,288 | 172,844,720 | 115,831,920 | 104,882,160 | 104,452,312 |
| Shares Outstanding, K | 258,053 | 536,435 | 110,186 | 2,027,100 | 1,245,853 |
| Annual Sales | 9,869,200,000 | 28,190,000,000 | 13,117,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 3,619,600,000 | 6,717,000,000 | 3,953,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 2,645,600,000 | 8,388,000,000 | 3,547,100,000 | 12,201,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -3,593,600,000 | 746,000,000 | 1,432,300,000 | 1,680,000,000 | 1,614,000,000 |
| 60-Month Beta | 0.40 | 0.61 | 0.12 | 0.46 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -12.83 on 08/01/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/04/24 | 10/30/24 | 10/31/24 | 10/31/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 07/05/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.35 | 27.14 | 37.16 | 17.79 |